🇺🇸 FDA
Patent

US 10716856

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

granted A61KA61K38/51A61K45/06

Quick answer

US patent 10716856 (Engineered primate cystine/cysteine degrading enzymes as antineogenic agents) held by The Board of Regents of the University of Texas System expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/51, A61K45/06, A61P, A61P35/00